Clinical Trial Update: Capsaicin for the Treatment of Cannabinoid Hyperemesis Syndrome [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating capsaicin for treatment of cannabinoid hyperemesis syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cannabinoid Hyperemesis Syndrome

Drugs mentioned

• Capsaicin (capsaicin)

Snippet

Sponsor: University of Virginia | Conditions: Cannabinoid Hyperemesis Syndrome | Phase 4 | Status: COMPLETED